Douglas Rhee, MD
Show Description +
Douglas Rhee, MD, spoke during Glaucoma Subspecialty Day at the ASCRS annual meeting about drug delivery and sustained-release devices. He examines the evidence behind existing and commercially available implants and reviews their comparable levels of IOP reduction and safety.
Posted: 5/01/2025
Douglas Rhee, MD
Douglas Rhee, MD, spoke during Glaucoma Subspecialty Day at the ASCRS annual meeting about drug delivery and sustained-release devices. He examines the evidence behind existing and commercially available implants and reviews their comparable levels of IOP reduction and safety.
Posted: 5/01/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2025.
Please log in to leave a comment.